SILENT 2

Belgium
|
2021-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Solan

Spain
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Immnunomodulator
  • Antineoplastic agent
  • Imatinib
  • Infliximab

Steinmetz

Germany
|
2021
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Stengel

Germany
|
2023
  • Adults
  • General population
  • Healthcare workers
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Stubbe

Germany
|
2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

SUEP

Germany
|
2020-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

TLC 

United Kingdom
|
2021
  • Adults
  • General population
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19

Vagus

Austria
|
2023-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

Villafañe

Spain
|
2023-2024
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Wildi

Argentina Australia Brazil Germany Hong Kong Italy Japan South Africa Spain United States of America Ireland
|
2020
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

PL-PC19

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Dietary
  • Lifestyle